Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-08

Clinical Trial Update: Evaluation of the Efficacy and Safety of an Intensified Strategy of Intratonsillar Immunotherapy (ITIT) for Allergic Rhinitis: A Multicenter, Randomized, Double-blind, Controlled Trial [NA]

View source ↗

Summary

Multicenter, randomized, double-blind trial assessing an intensified intratonsillar immunotherapy strategy for allergic rhinitis; trial status is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intensified Intratonsillar Immunotherapy (ITIT)

Snippet

Sponsor: Renmin Hospital of Wuhan University | Conditions: Allergic Rhinitis | NA | Status: NOT_YET_RECRUITING